|
English
|
正體中文
|
简体中文
|
總筆數 :2856655
|
|
造訪人次 :
53541892
線上人數 :
1362
教育部委託研究計畫 計畫執行:國立臺灣大學圖書館
|
|
|
"tsai y c"的相關文件
顯示項目 236-245 / 760 (共76頁)
<< < 19 20 21 22 23 24 25 26 27 28 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2021-02-04T02:30:26Z |
Predictive factors of post-laparoscopic inguinal hernia acute and chronic pain: prospective follow-up of 807 patients from a single experienced surgeon
|
Lo, C.-W.;Chen, Y.-T.;Jaw, F.-S.;Yu, C.-C.;Tsai, Y.-C.Fu-Shan Jaw; Lo, C.-W.; Chen, Y.-T.; Jaw, F.-S.; Yu, C.-C.; Tsai, Y.-C.; FU-SHAN JAW |
| 臺大學術典藏 |
2021-02-02T00:46:57Z |
Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based Regimens
|
Lin C.-C.;Hsu C.-H.;Huang C.-Y.;Tsai Y.-C.;Huang K.-H.;Cheng A.-L.;Yeong-Shiau Pu; Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Tsai Y.-C.; Huang K.-H.; Cheng A.-L.; YEONG-SHIAU PU |
| 臺大學術典藏 |
2021-02-02T00:46:57Z |
Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study
|
Lin C.-C.;Hsu C.-H.;Huang C.-Y.;Keng H.-Y.;Tsai Y.-C.;Huang K.-H.;Cheng A.-L.;Yeong-Shiau Pu; Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Keng H.-Y.; Tsai Y.-C.; Huang K.-H.; Cheng A.-L.; YEONG-SHIAU PU |
| 臺大學術典藏 |
2021-02-02T00:46:56Z |
Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer
|
Chen C.-H.;Shun C.-T.;Huang K.-H.;Huang C.-Y.;Tsai Y.-C.;Yu H.-J.;Yeong-Shiau Pu; Chen C.-H.; Shun C.-T.; Huang K.-H.; Huang C.-Y.; Tsai Y.-C.; Yu H.-J.; YEONG-SHIAU PU |
| 臺大學術典藏 |
2021-02-02T00:46:50Z |
Down regulation of ABCD1 in human renal cell carcinoma
|
Hour T.-C.; Kuo Y.-Z.; Liu G.-Y.; Kang W.-Y.; Huang C.-Y.; Tsai Y.-C.; Wu W.-J.; Huang S.-P.; YEONG-SHIAU PU |
| 臺大學術典藏 |
2021-02-02T00:46:47Z |
Induction Cisplatin and Fluorouracil-Based Chemotherapy Followed by Concurrent Chemoradiation for Muscle-Invasive Bladder Cancer
|
Lin C.-C.; Hsu C.-H.; Cheng J.C.; Huang C.-Y.; Tsai Y.-C.; Hsu F.-M.; Huang K.-H.; Cheng A.-L.; YEONG-SHIAU PU |
| 臺大學術典藏 |
2021-02-02T00:46:39Z |
Down-regulation of PKCζ in renal cell carcinoma and its clinicopathological implications.
|
YEONG-SHIAU PU; Huang C.Y.; Chen J.Y.; Kang W.Y.; Lin Y.C.; Shiu Y.S.; Chuang S.J.; Yu H.J.; Lai M.K.; Tsai Y.C.; Wu W.J.; Hour T.C. |
| 臺大學術典藏 |
2021-02-02T00:46:36Z |
Down-regulation of glucose-regulated protein (GRP) 78 potentiates cytotoxic effect of celecoxib in human urothelial carcinoma cells
|
Huang K.-H.; Kuo K.-L.; Chen S.-C.; Weng T.-I.; Chuang Y.-T.; Tsai Y.-C.; YEONG-SHIAU PU; Chiang C.-K.; Liu S.-H. |
| 臺大學術典藏 |
2021-02-02T00:46:32Z |
Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma
|
Tsai Y.-C.; Yeh C.-H.; Tzen K.-Y.; Ho P.-Y.; Tuan T.-F.; YEONG-SHIAU PU; Cheng A.-L.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-02-02T00:46:21Z |
MLN4924, a novel protein neddylation inhibitor, suppresses proliferation and migration of human urothelial carcinoma: In vitro and in vivo studies
|
Kuo K.-L.;Ho I.-L.;Shi C.-S.;Wu J.-T.;Lin W.-C.;Tsai Y.-C.;Chang H.-C.;Chou C.-T.;Hsu C.-H.;Hsieh J.-T.;Chang S.-C.;Yeong-Shiau Pu;Huang K.-H.; Kuo K.-L.; Ho I.-L.; Shi C.-S.; Wu J.-T.; Lin W.-C.; Tsai Y.-C.; Chang H.-C.; Chou C.-T.; Hsu C.-H.; Hsieh J.-T.; Chang S.-C.; YEONG-SHIAU PU; Huang K.-H. |
顯示項目 236-245 / 760 (共76頁)
<< < 19 20 21 22 23 24 25 26 27 28 > >>
每頁顯示[10|25|50]項目
|
